Company News for July 30, 2010 - Corporate Summary

• Google GOOG retracted from its last night's claims that its search engine was completely blocked in China, saying, "Because of the way we measure accessibility in China, it's possible that our machines could overestimate the level of blockage... It appears now that users in China are accessing our properties normally."

• Disney DIS announced sale of Miramax for over $660 million to Filmyard Holdings, a group of private investors

• Amgen AMGN reported inline guidance after the close of markets yesterday, with earnings of $1.38 beating estimates of $1.30 on better-than-expected revenues of $3.8 billion that topped estimates of $3.74 billion

• Aon Corporation AON posted second quarter earnings of 81 cents, 6 cents higher than estimated on in-line revenues of $1.89 billion, up 0.9% YoY

• Newell Rubbermaid NWL reported second quarter earnings of 51 cents, topping estimates by 7 cents, on inline revenues of $1.5 billion

• Merck MRK posted second quarter earnings of 86 cents, up from estimates of 83 cents, on revenues of $11.35 billion, that fell short of estimates of $11.47 billion. The company offered inline guidance of $3.29-$3.39

• McKesson MCK reported estimate-topping, fiscal first quarter earnings of $1.10 on revenues of $27.5 billion; consensus estimates called for earnings of $1.09 and revenues of $27.25 billion

• American Electric AEP posted second quarter earnings better-than-expected at 74 cents, up from estimates of 69 cents, on revenues of $3.4 billion, missing estimates of $3.48 billion

• Goldman Sachs GS removed Colgate-Palmolive CL from the firm's Conviction Buy List, lowering the rating to "neutral," with a price target of $86

Zacks Investment Research
Market News and Data brought to you by Benzinga APIs
Comments
Loading...
Posted In: BiotechnologyConsumer DiscretionaryConsumer StaplesFinancialsHealth CareHealth Care DistributorsHousehold ProductsHousewares & SpecialtiesInformation TechnologyInternet Software & ServicesInvestment Banking & BrokerageMovies & EntertainmentPharmaceuticalsUtilities
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!